Development
NeueHealth, Inc.
NEUE
$6.77
$0.000.00%
NYSE
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 7.04% | 26.10% | -6.73% | -23.75% | -199.76% |
| Total Depreciation and Amortization | -29.81% | -26.98% | -25.39% | 0.57% | 21.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 56.33% | 71.04% | 488.98% | 2,931.51% | 741.83% |
| Change in Net Operating Assets | -223.06% | -119.28% | -91.60% | -5.67% | 50.17% |
| Cash from Operations | -5,409.84% | -455.35% | -487.65% | 185.77% | -123.87% |
| Capital Expenditure | 74.56% | 59.57% | 24.83% | 9.75% | -20.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | 100.00% | 100.00% | 99.93% | 99.92% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 617.82% | 238.86% | 233.31% | -343.24% | -10.37% |
| Cash from Investing | 570.78% | 206.37% | 178.80% | 22.28% | 55.42% |
| Total Debt Issued | -122.88% | -3.91% | -3.91% | -58.04% | 129.47% |
| Total Debt Repaid | 200.00% | 200.00% | 143.66% | 100.00% | 22.50% |
| Issuance of Common Stock | -99.91% | -73.67% | -99.88% | -99.85% | -99.76% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -76.86% | -76.86% | -76.86% | -- | 2,968.48% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -300.05% | -4.25% | -12.88% | 57.22% | 79.84% |
| Cash from Financing | -79.57% | -36.54% | -67.15% | 2.18% | 15.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -137.00% | 829.38% | -6.21% | 52.08% | 146.84% |